ask="56.00"
ask_size="200"
average_daily_volume="536789"
bid="48.87"
bid_size="500"
book_value="11.13"
change="-0.86"
change_from_200_day_moving_average="3.65"
change_from_50_day_moving_average="-2.01"
change_from_52_week_high="-7.47"
change_From_52_week_low="22.70"
change_in_percent="-1.73%"
close="48.98"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.20"
ebitda="-132.17M"
eps_estimate_current_year="-4.36"
eps_estimate_next_quarter="-1.25"
eps_estimate_next_year="-5.05"
ex_dividend_date="N/A"
float_shares="32769000"
high="51.18"
high_52_weeks="56.45"
last_trade_date="1/25/2017"
last_trade_price="48.98"
last_trade_size="11400"
last_trade_time="4:00pm"
low="48.95"
low_52_weeks="26.28"
market_capitalization="1.82B"
moving_average_200_day="45.33"
moving_average_50_day="50.99"
name="Sage Therapeutics
Inc."
notes="N/A"
one_year_target_price="75.27"
open="50.27"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+8.06%"
percent_change_from_50_day_moving_average="-3.95%"
percent_change_from_52_week_high="-13.23%"
percent_change_from_52_week_low="+86.38%"
previous_close="49.84"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.48"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="37167000"
short_ratio="7.11"
stock_exchange="NGM"
symbol="SAGE"
volume="507119"
weeks_range_52="26.28 - 56.45"
